Curtiss-Wright achieves unprecedented financial performance in 2023, with strong growth expected in 2024. Investor Day event to discuss long-term strategy ...
Lexaria Bioscience announces a $3.6 million offering and private placement to enhance operational capabilities and drive innovation in the pharmaceutical ...